CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 30  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0682
LYS 10.0682
GLU 20.0222
LEU 30.0278
ARG 40.0352
CYS 50.0226
GLN 60.0243
CYS 70.0160
ILE 80.0184
LYS 90.0132
THR 100.0037
TYR 110.0074
SER 120.0094
LYS 130.0084
PRO 140.0122
PHE 150.0084
HIS 160.0145
PRO 170.0093
LYS 180.0058
PHE 190.0064
ILE 200.0078
LYS 210.0160
GLU 220.0136
LEU 230.0041
ARG 240.0186
VAL 250.0182
ILE 260.0215
GLU 270.0156
SER 280.0047
GLY 290.0320
PRO 300.0596
HIS 310.0588
CYS 320.0438
ALA 330.0427
ASN 340.0314
THR 350.0253
GLU 360.0194
ILE 370.0065
ILE 380.0095
VAL 390.0056
LYS 400.0088
LEU 410.0073
SER 420.0228
ASP 430.0280
GLY 440.0081
ARG 450.0270
GLU 460.0183
LEU 470.0088
CYS 480.0054
LEU 490.0026
ASP 500.0056
PRO 510.0082
LYS 520.0085
GLU 530.0097
ASN 540.0185
TRP 550.0130
VAL 560.0070
GLN 570.0104
ARG 580.0124
VAL 590.0085
VAL 600.0068
GLU 610.0126
LYS 620.0110
PHE 630.0099
LEU 640.0110
LYS 650.0099
ARG 660.0072
ALA 670.0060
GLU 680.0053
ASN 690.0248

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.